Center for Innovation in Global Health, Georgetown University, Washington, DC, USA.
National AIDS Control Council, Nairobi, Kenya.
Lancet HIV. 2021 May;8(5):e306-e310. doi: 10.1016/S2352-3018(20)30278-2. Epub 2021 Feb 9.
Indicators for the measurement of programmes for the primary prevention of HIV are less aligned than indicators for HIV treatment, which results in a high burden of data collection, often without a clear vision for its use. As new evidence becomes available, the opportunity arises to critically evaluate the way countries and global bodies monitor HIV prevention programmes by incorporating emerging data on the strength of the evidence linking various factors with HIV acquisition, and by working to streamline indicators across stakeholders to reduce burdens on health-care systems. Programmes are also using new approaches, such as targeting specific sexual networks that might require non-traditional approaches to measurement. Technological advances can support these new directions and provide opportunities to use real-time analytics and new data sources to more effectively understand and adapt HIV prevention programmes to reflect population movement, risks, and an evolving epidemic.
衡量艾滋病毒初级预防规划的指标不如艾滋病毒治疗的指标明确，这导致数据收集负担沉重，而且往往不清楚数据的用途。随着新证据的出现，各国和全球机构有机会通过纳入新的证据，认真评估监测艾滋病毒预防规划的方式，这些新证据将各种因素与艾滋病毒感染联系起来，并努力简化利益攸关方的指标，以减轻卫生保健系统的负担。规划还在采用新方法，例如针对特定的性网络，这可能需要采用非传统的方法来衡量。技术进步可以支持这些新方向，并提供机会利用实时分析和新数据源，更有效地了解和调整艾滋病毒预防规划，以反映人口流动、风险和不断演变的疫情。
